CIURLEO, ROSELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.365
EU - Europa 997
AS - Asia 288
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 2.653
Nazione #
US - Stati Uniti d'America 1.358
SE - Svezia 331
IE - Irlanda 327
CN - Cina 217
UA - Ucraina 98
DE - Germania 78
IT - Italia 58
VN - Vietnam 52
FI - Finlandia 46
GB - Regno Unito 25
IN - India 15
AT - Austria 8
BE - Belgio 8
CA - Canada 7
NL - Olanda 6
RU - Federazione Russa 5
FR - Francia 3
HK - Hong Kong 2
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EU - Europa 1
LA - Repubblica Popolare Democratica del Laos 1
PT - Portogallo 1
RO - Romania 1
SG - Singapore 1
Totale 2.653
Città #
Dublin 327
Chandler 315
Nyköping 222
Jacksonville 193
Ashburn 104
Dearborn 87
Beijing 78
Princeton 56
Dong Ket 52
Medford 49
Cambridge 46
New York 44
Des Moines 43
Boardman 34
Jinan 23
Ann Arbor 18
Nanjing 18
Hebei 17
Wilmington 12
Woodbridge 12
Bremen 11
Brussels 8
Hyderabad 8
Taiyuan 8
Taizhou 8
Vienna 8
Lancaster 7
Washington 7
Montréal 6
Shenyang 6
Nanchang 5
Tianjin 5
Catania 4
Changsha 4
Fuzhou 4
Haikou 4
Hefei 4
San Mateo 4
Seattle 4
West Jordan 4
Zhengzhou 4
Falls Church 3
Hangzhou 3
Jiaxing 3
Mcallen 3
Milan 3
Pietra Ligure 3
Turin 3
Auburn Hills 2
Campi Bisenzio 2
Guangzhou 2
Helsinki 2
Houston 2
Kunming 2
London 2
Los Angeles 2
Messina 2
Monmouth Junction 2
Munich 2
Ningbo 2
Pavia 2
Pune 2
Wuhan 2
Xian 2
Albuquerque 1
Berlin 1
Brooklyn 1
Canelli 1
Cedar Knolls 1
Chengdu 1
Chicago 1
Clearwater 1
Edinburgh 1
Giarre 1
Hanover 1
Lausanne 1
Lecce 1
Lisbon 1
Mansfield 1
Meppel 1
Nanning 1
New Delhi 1
Newark 1
Norwalk 1
Nuremberg 1
Perugia 1
Porto Potenza Picena 1
Quzhou 1
Redwood City 1
Rende 1
Rome 1
San Giovanni La Punta 1
Sant'Agata di Militello 1
Santa Clara 1
Serra 1
Singapore 1
Tavernerio 1
Torino 1
Toronto 1
Vitória da Conquista 1
Totale 1.962
Nome #
(1)H-MR Spectroscopy in Traumatic Brain Injury. 201
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 76
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 72
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 68
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 67
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 67
1H Magnetic Resonance Spectroscopy of the brain: methods for absolute quantification of metabolites 67
Diffusion - weighted imaging and fluid-attenuated inversion recovery sequence in sporadic Creutzfeldt-Jakob disease. One - case report. 67
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 63
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 63
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 63
Functional connectivity in vegetative state patients 62
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 62
Cortical reorganization in multiple sclerosis after intrathecal baclofen therapy. 60
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 58
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 57
Neurophysiological approach in comatose patients 56
Functional neuroimaging in differential diagnosis and outcome assessment of patients with disorders of consciousness 55
Automatic Algorithm for Segmentation of Atherosclerotic Carotid Plaque 54
Reality orientation therapy (ROT) in Alzheimer’s disease. 53
Nuovi inibitori competitivi non fosforilati delle fosfotirosina protein fosfatasi. 52
ROLE OF MAGNETIC RESONANCE SPECTROSCOPIC IN THE METABOLIC CHANGES IN DE NOVO PARKINSON’S DISEASE AFTER DOPAMINERGIC THERAPY 52
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 50
“2,4-Thiazolidinedione derivatives as potential agents for the treatment of type 2 diabetes and its chronic complications” 48
Functional evaluation of awareness in vegetative and minimally conscious state 48
Nuovi 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 45
Nuovi 5-ariliden-2,4-tiazolidindioni non carbossilici inibitori dell'aldoso reduttasi 45
The clinical use of quality of life scales in the neurodegenerative diseases 44
ROLE OF RESVERATROL AND ITS ANALOGUES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES: FOCUS ON RECENT DISCOVERIES, 42
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives 41
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 40
Evaluation of olfactory dysfunction in neurodegenerative diseases. 40
RUOLO DELLA RISONANZA MAGNETICA SPETTROSCOPICA NELLO STUDIO DELLE ALTERAZIONI METABOLICHE NELLA MALATTIA DI PARKINSON IN SEGUITO A TERAPIA DOPAMINERGICA 39
The role of sativex in robotic rehabilitation in individuals with multiple sclerosis rationale, study design, and methodology 39
Evaluation of olfactory dysfunction in neurodegenerative diseases 38
Neurorehabilitation as a multidisciplinary approach: amyotrophic lateral sclerosis 37
Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries 37
null 37
Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia 37
Titolo: Ruolo della risonanza magnetica spettroscopica nello studio delle alterazioni metaboliche nella malattia di Parkinson in seguito a terapia dopaminergica 34
Post-traumatic olfactory loss: Psychophysical, electrophysiological and neuroradiological findings in three single case studies 32
Propranolol for familial cerebral cavernous malformation (Treat_CCM): Study protocol for a randomized controlled pilot trial 30
Effects of diffusion signal modeling and segmentation approaches on subthalamic nucleus parcellation 29
Sintesi e valutazione in vitro di 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori di protein tirosina fosfatasi 29
Role of statins in the treatment of multiple sclerosis 29
Olfactory event-related potentials in a functionally anosmic patient with arrested hydrocephalus 28
Transcriptomic data analysis reveals a down-expression of galectin-8 in schizophrenia hippocampus 28
Neurogenic ejaculatory disorders: focus on current and future treatments. 27
Ventral intermediate nucleus structural connectivity-derived segmentation: anatomical reliability and variability 26
Persistent anosmia in a traumatic brain injury patient: role of orbitofrontal cortex. 24
Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study 23
The role of brain oscillations in post-stroke motor recovery: An overview 22
Magnetic Resonance Spectroscopy: An In Vivo Molecular Imaging Biomarker for Parkinson’s Disease? 22
Striatal topographical organization: Bridging the gap between molecules, connectivity and behavior 21
In Vivo Super-Resolution Track-Density Imaging for Thalamic Nuclei Identification 19
In vivo probabilistic atlas of white matter tracts of the human subthalamic area combining track density imaging and optimized diffusion tractography 18
Pharmacotherapy for disorders of consciousness: are 'awakening' drugs really a possibility? 16
White matter substrates of functional connectivity dynamics in the human brain 15
Role of diffusion tensor imaging in the diagnosis and management of post-traumatic anosmia 5
Totale 2.679
Categoria #
all - tutte 9.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/2020407 50 18 0 18 22 67 87 52 5 21 65 2
2020/2021281 34 0 41 14 16 38 0 18 1 32 21 66
2021/2022334 2 24 7 8 31 1 55 6 8 15 48 129
2022/20231.122 95 114 44 97 92 124 27 56 425 8 28 12
2023/2024288 21 45 22 35 30 96 1 20 2 14 2 0
Totale 2.679